K. Haider

Randomized Adjuvant Trial of Tamoxifen and Goserelin Versus Cyclophosphamide, Methotrexate, and Fluorouracil: Evidence for the Superiority of Treatment With Endocrine Blockade in Premenopausal Patients With Hormone-Responsive Breast Cancer—Austrian Breast and Colorectal Cancer Study Group Trial 5

R. Jakesz, H. Hausmaninger, E. Kubista et al. · Journal of Clinical Oncology · 2002 · 288 citations

Medicine, Oncology, Pharmacology +17

Lumpectomy Plus Tamoxifen or Anastrozole With or Without Whole Breast Irradiation in Women With Favorable Early Breast Cancer

Richard Pötter, Michael Gnant, W. Kwasny et al. · International Journal of Radiation Oncology*Biology*Physics · 2007 · 224 citations

Medicine, Gynecology, Oncology +10

Biweekly high-dose gemcitabine alone or in combination with capecitabine in patients with metastatic pancreatic adenocarcinoma: a randomized phase II trial

Werner Scheithauer, B. Schüll, H. Ulrich-Pur et al. · Annals of Oncology · 2002 · 187 citations · Full text

Medicine, Oncology, Pharmacology +14

Irinotecan plus raltitrexed vs raltitrexed alone in patients with gemcitabine-pretreated advanced pancreatic adenocarcinoma

H. Ulrich-Pur, Markus Raderer, Gabriela Kornek et al. · British Journal of Cancer · 2003 · 117 citations · Full text

Medicine, Oncology, Pharmacology +15

Tamoxifen and Anastrozole As a Sequencing Strategy: A Randomized Controlled Trial in Postmenopausal Patients With Endocrine-Responsive Early Breast Cancer From the Austrian Breast and Colorectal Cancer Study Group

Peter Dubsky, R. Jakesz, Brigitte Mlineritsch et al. · Journal of Clinical Oncology · 2012 · 99 citations

Medicine, Oncology, Pharmacology +16